• Markets
    • icon
  • Companies
RGS · ASX

Regeneus Ltd. (ASX:RGS)

AU$0.004

 0.0 (0.0%)
ASX:Live
01/12/2023 04:10:47 PM
Volume Spike (Realtime) Near Support (Realtime) Near Support Near 52 Week Low HALO Ords +3
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

RGS Overview

RGS Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About RGS

Website

N/A

Telephone

61.2.9499.8010

Address

16 Goodhope Street Paddington, New South Wales (NSW) 2021

Description

Regeneus Ltd. is regenerative medicine company, which develops and commercializes innovative cell-based therapies to address unmet medical needs in human and veterinary health. The company was founded by Ben Herbert and Graham Vesey on August 14, 2007 and is headquartered in Paddington, Australia.

RGS Price Chart

Key Stats

Market Cap

AU$1.23M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.0 - 0.05

Trade Value (12mth)

AU$1,057.00

1 week

0%

1 month

0%

YTD

-90%

1 year

-90.7%

All time high

0.645113

Key Fundamentals

EPS 3 yr Growth

61.800%

EBITDA Margin

N/A

Operating Cashflow

-$1m

Free Cash Flow Return

-138.70%

ROIC

-354.30%

Interest Coverage

-6.40

Quick Ratio

1.00

Other Data

Shares on Issue (Fully Dilluted)

0m

HALO Sector

Healthcare

Next Company Report Date

29-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

RGS Announcements

Latest Announcements

Date Announcements

31 October 23

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

31 October 18

Presentation for AusBiotech 2018

×

Presentation for AusBiotech 2018

31 May 17

RGS presentation to ChinaBio Partnering Forum

×

RGS presentation to ChinaBio Partnering Forum

31 July 23

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

31 July 23

Notification of cessation of securities - RGS

×

Notification of cessation of securities - RGS

31 January 23

Notice of Termination of Kyocera Licence

×

Notice of Termination of Kyocera Licence

31 January 23

Quarterly Activities/Appendix 4C Cash Flow Report

×

Quarterly Activities/Appendix 4C Cash Flow Report

31 August 23

Appendix 4E - Preliminary final report-unaudited

×

Appendix 4E - Preliminary final report-unaudited

31 August 15

FY15 Full-Year Results and Business Update Presentation

×

FY15 Full-Year Results and Business Update Presentation

30 September 22

Date of AGM

×

Date of AGM

30 October 20

Annual Report Additional Information

×

Annual Report Additional Information

30 October 19

Annual Report 2019

×

Annual Report 2019

30 November 23

Chairman's Address and CEO update

×

Chairman's Address and CEO update

30 November 23

Results of Annual General Meeting

×

Results of Annual General Meeting

30 June 22

Notification of cessation of securities - RGS

×

Notification of cessation of securities - RGS

30 January 23

Trading Halt

×

Trading Halt

30 August 22

Preliminary Final Report

×

Preliminary Final Report

30 August 22

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

30 August 18

Annual Report 2018

×

Annual Report 2018

30 August 18

FY18 Results and Business Update Presentation

×

FY18 Results and Business Update Presentation

29 September 23

Annual Report 2023

×

Annual Report 2023

29 September 23

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

29 October 13

Annual Report to shareholders

×

Annual Report to shareholders

29 October 13

Investor presentation - ASX Spotlight Conference, Singapore

×

Investor presentation - ASX Spotlight Conference, Singapore

29 October 13

Investor presentation - ASX Spotlight Conference, Singapore

×

Investor presentation - ASX Spotlight Conference, Singapore

29 November 22

Chairman's Address and CEO presentation

×

Chairman's Address and CEO presentation

29 November 22

Results of Annual General Meeting

×

Results of Annual General Meeting

29 November 22

Change of Auditor

×

Change of Auditor

RGS Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.01 -0.01 -0.01 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.01 -0.01 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 373.5 -251.6 61.0 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.01 -0.01 -0.00 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.01 -0.01 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 194.8 -213.3 65.5 Lock Lock Lock
     Yield % Lock Lock Lock Lock 11.0 -19.3 -30.8 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.01 0.00 -0.00 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.01 0.00 -0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 246.8 -74.3 -111.6 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 296 306 306 Lock Lock Lock
Basic m Lock Lock Lock Lock 296 306 306 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 7 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock 324.9 -100.0 N/A Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 5 5 2 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock N/A 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A 74.3 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 2 -5 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock 152.8 -373.7 51.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock 23.9 N/A N/A Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 2 -5 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock 149.9 -384.3 51.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 23.1 N/A N/A Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 2 -5 -3 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -1 -1 -1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 3 -4 -2 Lock Lock Lock
     Growth % Lock Lock Lock Lock 408.6 -256.2 60.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock 39.0 N/A N/A Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 2 -4 -1 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 0 0 1 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 2 -4 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock 224.1 -249.3 81.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.3 N/A N/A Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 4 0 0 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 9 3 2 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -4 1 0 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 4 1 3 Lock Lock Lock
Equity $m Lock Lock Lock Lock 4 1 0 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 4 1 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock 275.0 -74.1 -111.6 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 32.4 -168.7 -68.4 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 66.6 -401.0 1,350.0 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 63.6 -149.0 -195.1 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 136.7 -164.8 -354.3 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 119.8 -137.3 -138.7 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock 4.2 -63.7 -6.4 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock -2.2 -0.2 -0.0 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -91.2 85.0 -35.4 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 5.2 0.5 1.0 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 5.2 0.5 1.0 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 56.4 12.1 12.3 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 186.5 -243.2 -25.5 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 2.6 0.0 0.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 1.3 N/A 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 12.3 N/A 0.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.8 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.8 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 27.0 N/A 0.0 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 22.4 N/A 0.0 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock -44.6 N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 32.4 -168.7 -68.4 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 2.1 2.4 -19.7 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 66.6 -401.0 1,350.0 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 66.6 -401.0 1,350.0 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 139.5 N/A 0.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 139.5 N/A 0.0 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock N/A 7,525.8 11,774.2 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 139.5 -7,525.8 -11,774.2 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

RGS Shortsell

Frequently Asked Questions

The current share price of Regeneus Ltd. (RGS:ASX) is AU$0.004.
The 52-week high share price for Regeneus Ltd. (RGS:ASX) is AU$0.05.
The 52-week low share price for Regeneus Ltd. (RGS:ASX)? is AU$0.00.
Regeneus Ltd. (RGS:ASX) does not pay a dividend.
Regeneus Ltd. (RGS:ASX) does not pay a dividend.
Regeneus Ltd. (RGS:ASX) has a franking level of 0%.
Regeneus Ltd. (RGS:ASX) is classified in the Healthcare.
The current P/E ratio for Regeneus Ltd. (RGS:ASX) is .
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.